Výsledky vyhledávání

Akademický článek

Predictive Signatures for Responses to Checkpoint Blockade in Small-Cell Lung Cancer in Second-Line Therapy Do Not Predict Responses in First-Line Patients.

Autor: Thompson JC; Division of Pulmonary, Allergy and Critical Care Medicine, Thoracic Oncology Group, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, 228 Stemmler Hall, 3450 Hamilton Walk, Philadelphia, PA 19104, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Tilsed C; Division of Pulmonary, Allergy and Critical Care Medicine, Thoracic Oncology Group, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, 228 Stemmler Hall, 3450 Hamilton Walk, Philadelphia, PA 19104, USA., Davis C; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Gupta A; Division of Pulmonary, Allergy and Critical Care Medicine, Thoracic Oncology Group, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, 228 Stemmler Hall, 3450 Hamilton Walk, Philadelphia, PA 19104, USA., Melidosian B; Incyte, Wilmington, DE 19803, USA., Sun C; Incyte, Wilmington, DE 19803, USA., Kallen ME; Department of Pathology, University of Maryland School of Medicine, Baltimore, MD 21201, USA., Timmers C; Incyte, Wilmington, DE 19803, USA., Langer CJ; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Albelda SM; Division of Pulmonary, Allergy and Critical Care Medicine, Thoracic Oncology Group, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, 228 Stemmler Hall, 3450 Hamilton Walk, Philadelphia, PA 19104, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

Publikováno v: Cancers [Cancers (Basel)] 2024 Aug 08; Vol. 16 (16). Date of Electronic Publication: 2024 Aug 08.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Transcriptomic analysis-guided assessment of precision-cut tumor slices (PCTS) as an ex-vivo tool in cancer research.

Autor: Trivedi S; Division of Hematology and Oncology, Department of Medicine, University of North Carolina at Chapel Hill, Charlotte, NC, USA., Tilsed C; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Center for Cellular Immunology, University of Pennsylvania, Philadelphia, PA, USA., Liousia M; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Center for Cellular Immunology, University of Pennsylvania, Philadelphia, PA, USA., Brody RM; Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania, Philadelphia, PA, USA., Rajasekaran K; Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania, Philadelphia, PA, USA., Singhal S; Division of Thoracic Surgery, Department of Surgery, University of Pennsylvania, Philadelphia, PA, USA., Albelda SM; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Center for Cellular Immunology, University of Pennsylvania, Philadelphia, PA, USA., Klampatsa A; Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK. astero.klampatsa@icr.ac.uk.

Publikováno v: Scientific reports [Sci Rep] 2024 May 14; Vol. 14 (1), pp. 11006. Date of Electronic Publication: 2024 May 14.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Outcome of a screening programme for the prevention of neonatal invasive early-onset group B Streptococcus infection in a UK maternity unit: an observational study

Autor: Gopal Rao, G, Nartey, G, McAree, T, O'Reilly, A, Hiles, S, Lee, T, Wallace, S, Batura, R, Khanna, P, Abbas, H, Tilsed, C, Nicholl, R, Lamagni, T, Bassett, P

Publikováno v: BMJ Open

Background Against a background of failure to prevent neonatal invasive early-onset group B Streptococcus infections (GBS) in our maternity unit using risk-based approach for intrapartum antibiotic prophylaxis, we introduced an antenatal GBS carriage

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::3bf77d7f0d3e6c59d482486b45537052
http://europepmc.org/articles/PMC5541438

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Functionalized Polymeric Micelles for Targeted Cancer Therapy: Steps from Conceptualization to Clinical Trials.

Autor: Serras, Ana¹ (AUTHOR) anafiserras@hotmail.com, Faustino, Célia¹ (AUTHOR) cfaustino@ff.ulisboa.pt, Pinheiro, Lídia¹ (AUTHOR)

Publikováno v: Pharmaceutics. Aug2024, Vol. 16 Issue 8, p1047. 57p.

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Combination immune checkpoint blockade as an effective therapy for mesothelioma.

Autor: Fear VS; National Centre for Asbestos Related Diseases (NCARD). Lv5 QQ Block (M503). QEII Medical Centre, The University of Western Australia, Perth, Australia.; School of Biomedical Sciences, The University of Western Australia, Perth, Australia., Tilsed C; National Centre for Asbestos Related Diseases (NCARD). Lv5 QQ Block (M503). QEII Medical Centre, The University of Western Australia, Perth, Australia.; School of Biomedical Sciences, The University of Western Australia, Perth, Australia., Chee J; National Centre for Asbestos Related Diseases (NCARD). Lv5 QQ Block (M503). QEII Medical Centre, The University of Western Australia, Perth, Australia.; School of Biomedical Sciences, The University of Western Australia, Perth, Australia., Forbes CA; National Centre for Asbestos Related Diseases (NCARD). Lv5 QQ Block (M503). QEII Medical Centre, The University of Western Australia, Perth, Australia.; School of Biomedical Sciences, The University of Western Australia, Perth, Australia., Casey T; National Centre for Asbestos Related Diseases (NCARD). Lv5 QQ Block (M503). QEII Medical Centre, The University of Western Australia, Perth, Australia.; School of Biomedical Sciences, The University of Western Australia, Perth, Australia., Solin JN; National Centre for Asbestos Related Diseases (NCARD). Lv5 QQ Block (M503). QEII Medical Centre, The University of Western Australia, Perth, Australia., Lansley SM; Centre for Respiratory Health, School of Biomedical Sciences, University of Western Australia, Perth, Australia., Lesterhuis WJ; National Centre for Asbestos Related Diseases (NCARD). Lv5 QQ Block (M503). QEII Medical Centre, The University of Western Australia, Perth, Australia.; School of Biomedical Sciences, The University of Western Australia, Perth, Australia., Dick IM; National Centre for Asbestos Related Diseases (NCARD). Lv5 QQ Block (M503). QEII Medical Centre, The University of Western Australia, Perth, Australia.; School of Biomedical Sciences, The University of Western Australia, Perth, Australia., Nowak AK; National Centre for Asbestos Related Diseases (NCARD). Lv5 QQ Block (M503). QEII Medical Centre, The University of Western Australia, Perth, Australia.; School of Medicine, The University of Western Australia, Perth, Australia., Robinson BW; National Centre for Asbestos Related Diseases (NCARD). Lv5 QQ Block (M503). QEII Medical Centre, The University of Western Australia, Perth, Australia.; School of Medicine, The University of Western Australia, Perth, Australia., Lake RA; National Centre for Asbestos Related Diseases (NCARD). Lv5 QQ Block (M503). QEII Medical Centre, The University of Western Australia, Perth, Australia.; School of Medicine, The University of Western Australia, Perth, Australia., Fisher SA; National Centre for Asbestos Related Diseases (NCARD). Lv5 QQ Block (M503). QEII Medical Centre, The University of Western Australia, Perth, Australia.; School of Biomedical Sciences, The University of Western Australia, Perth, Australia.

Publikováno v: Oncoimmunology [Oncoimmunology] 2018 Jul 30; Vol. 7 (10), pp. e1494111. Date of Electronic Publication: 2018 Jul 30 (Print Publication: 2018).

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání